Mari Raki

1.7k total citations
26 papers, 720 citations indexed

About

Mari Raki is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Mari Raki has authored 26 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Genetics and 13 papers in Oncology. Recurrent topics in Mari Raki's work include Virus-based gene therapy research (15 papers), CAR-T cell therapy research (12 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Mari Raki is often cited by papers focused on Virus-based gene therapy research (15 papers), CAR-T cell therapy research (12 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Mari Raki collaborates with scholars based in Finland, United States and Germany. Mari Raki's co-authors include Anna Kanerva, Akseli Hemminki, Merja Särkioja, Kim Bergström, Lotta Kangasniemi, Tuuli Ranki, Arto Urtti, Ari Ristimäki, R A Desmond and Marjo Yliperttula and has published in prestigious journals such as PLoS ONE, Biomaterials and Cancer.

In The Last Decade

Mari Raki

26 papers receiving 705 citations

Peers

Mari Raki
Reinhard Waehler United States
Eonju Oh South Korea
Liujiang Song United States
Eran Bram Israel
Reinhard Waehler United States
Mari Raki
Citations per year, relative to Mari Raki Mari Raki (= 1×) peers Reinhard Waehler

Countries citing papers authored by Mari Raki

Since Specialization
Citations

This map shows the geographic impact of Mari Raki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Raki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Raki more than expected).

Fields of papers citing papers by Mari Raki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Raki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Raki. The network helps show where Mari Raki may publish in the future.

Co-authorship network of co-authors of Mari Raki

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Raki. A scholar is included among the top collaborators of Mari Raki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Raki. Mari Raki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raki, Mari, Kim Bergström, Sarah Rose, et al.. (2019). Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusers. Journal of Neural Transmission. 127(5). 707–714. 6 indexed citations
2.
Kallionpää, Roope A., Susanne Bäck, Mirkka Sarparanta, et al.. (2014). Synthesis and biological evaluation of novel 123I-labeled 4-(4-iodophenyl)butanoyl-l-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo. European Journal of Medicinal Chemistry. 79. 436–445. 2 indexed citations
3.
Raki, Mari, et al.. (2014). Radiolabeled Peptides for Alzheimer’s Diagnostic Imaging: Mini Review. Current Radiopharmaceuticals. 6(4). 181–191. 6 indexed citations
4.
Laurén, Patrick, Yan‐Ru Lou, Mari Raki, et al.. (2014). Technetium-99m-labeled nanofibrillar cellulose hydrogel for in vivo drug release. European Journal of Pharmaceutical Sciences. 65. 79–88. 50 indexed citations
5.
Laurinmäki, Pasi, Sarah J. Butcher, Mari Raki, et al.. (2013). SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications. Biomaterials. 34(33). 8491–8503. 65 indexed citations
6.
Bäck, Susanne, Mari Raki, Raimo K. Tuominen, et al.. (2013). High correlation between in vivo [123I]β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats. EJNMMI Research. 3(1). 46–46. 25 indexed citations
7.
Pitkonen, Miia, Eero Hippeläinen, Mari Raki, et al.. (2012). Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT. EJNMMI Research. 2(1). 55–55. 2 indexed citations
8.
Liikanen, Ilkka, Vladia Monsurrò, Laura Ahtiainen, et al.. (2011). Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus. Molecular Therapy. 19(10). 1858–1866. 39 indexed citations
9.
Raki, Mari, Merja Särkioja, Sophie Escutenaire, et al.. (2011). Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients. The Journal of Gene Medicine. 13(5). 253–261. 28 indexed citations
10.
Koski, Anniina, Mari Raki, Petri Nokisalmi, et al.. (2011). Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer. Molecular Therapy. 20(1). 221–229. 28 indexed citations
11.
Särkioja, Merja, Sari Pesonen, Mari Raki, et al.. (2008). Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies. Gene Therapy. 15(12). 921–929. 31 indexed citations
12.
Kanerva, Anna, Sergio Lavilla-Alonso, Mari Raki, et al.. (2008). Systemic Therapy for Cervical Cancer with Potentially Regulatable Oncolytic Adenoviruses. PLoS ONE. 3(8). e2917–e2917. 15 indexed citations
13.
Kanerva, Anna, Mari Raki, & Akseli Hemminki. (2007). Gene therapy of gynaecological diseases. Expert Opinion on Biological Therapy. 7(9). 1347–1361. 14 indexed citations
14.
Raki, Mari, Merja Särkioja, Renée A. Desmond, et al.. (2007). Oncolytic adenovirus Ad5/3-Δ24 and chemotherapy for treatment of orthotopic ovarian cancer. Gynecologic Oncology. 108(1). 166–172. 35 indexed citations
15.
Raki, Mari, Gerd Bauerschmitz, Merja Särkioja, et al.. (2007). Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus. Gene Therapy. 14(19). 1380–1388. 34 indexed citations
16.
Raki, Mari, Daniel Rein, Anna Kanerva, & Akseli Hemminki. (2006). Gene Transfer Approaches for Gynecological Diseases. Molecular Therapy. 14(2). 154–163. 28 indexed citations
17.
Kanerva, Anna, Mari Raki, Tuuli Ranki, et al.. (2006). Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity. The Journal of Gene Medicine. 9(1). 3–9. 23 indexed citations
18.
Särkioja, Merja, Anna Kanerva, Jarmo Salo, et al.. (2006). Noninvasive imaging for evaluation of the systemic delivery of capsid‐modified adenoviruses in an orthotopic model of advanced lung cancer. Cancer. 107(7). 1578–1588. 29 indexed citations
20.
Raki, Mari, Anna Kanerva, Ari Ristimäki, et al.. (2005). Combination of gemcitabine and Ad5/3-Δ24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer. Gene Therapy. 12(15). 1198–1205. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026